Arip Koyshybaev
Research Subjects
Arip Koyshybaev has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Nauryzbay Imanbayev
NJSC «Marat Ospanov West Kazakhstan Medical University», Department of Oncology. Aktobe, Kazakhstan
5 shared publications - Saule Balmagambetova
Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe 030019, Kazakhstan
5 shared publications - Azamat Zharylgapov
Department of Evidence-Based Medicine and Scientific Management, West Kazakhstan Marat Ospanov Medical University, Aktobe 030000, Kazakhstan
4 shared publications - Nurgul Kereyeva
«West Kazakhstan Marat Ospanov Medical University» NSJSC
4 shared publications - Olzhas Urazayev
«Marat Ospanov West Kazakhstan Medical University» NCJSC
4 shared publications - Ainel Urazova
Department of Oncology, West Kazakhstan Marat Ospanov State Medical University, Aktobe, Kazakhstan
3 shared publications
Latest Publications
- Open Access
- 18 August 2026
- Published by MDPI AG in Nursing Reports
- Vol. 16 (8) , 288
Caregiving Experiences, Supportive Care Needs and Coping Strategies Among Family Caregivers of Patients with Colorectal Cancer in Kazakhstan: A Qualitative Descriptive Study
Background: Family caregivers play a central role in supporting people with colorectal cancer (CRC) and often manage complex physical, emotional, and practical demands. However, evidence regarding their experiences and supportive care needs in Kazakhstan remains limited. This qualitative study explored caregiving experiences, caregiving burden, caregivers’ needs, and coping strategies. Methods: A qualitative descriptive design was used, involving semi-structured interviews with 21 family caregivers caring for patients with CRC. Participants were recruited purposively from the Medical Center of West Kazakhstan Marat Ospanov Medical University and outpatient clinics in Aktobe between December 2025 and March 2026. Interviews were audio-recorded, transcribed verbatim, and analyzed using inductive reflexive thematic analysis. Results: Most family caregivers of patients with colorectal cancer were women (95.2%). Five main themes developed: emotional challenges, transformation of daily life, caregiving tasks, caregivers’ needs and support gaps, and coping strategies and resilience. Diagnosis was described as a distressing experience characterized by shock, fear, and uncertainty. Caregiving substantially disrupted employment, financial stability, and family roles, often requiring work adjustment or leaving the workforce. Caregivers reported insufficient preparation for stoma care and expressed a strong need for structured training. Social isolation was common, as both caregivers and patients experienced a shrinking of their social support networks. Despite substantial burden, caregivers described adaptive responses to ongoing emotional and practical demands, and resilience was a prominent theme. Conclusions: Family caregivers of patients with colorectal cancer in Kazakhstan face interconnected emotional, informational, physical, and system-level challenges, while also drawing on resilience. The findings highlight priorities for support, including structured stoma care education, psychological services, recognition of caregivers’ roles, and improved discharge and transitional care.
- 18 August 2026
- Published by MDPI AG in Nursing Reports
- Vol. 16 (8) , 288
Open AccessCaregiving Experiences, Supportive Care Needs and Coping Strategies Among Family Caregivers of Patients with Colorectal Cancer in Kazakhstan: A Qualitative Descriptive Study
Background: Family caregivers play a central role in supporting people with colorectal cancer (CRC) and often manage complex physical, emotional, and practical demands. However, evidence regarding their experiences and supportive care needs in Kazakhstan remains limited. This qualitative study explored caregiving experiences, caregiving burden, caregivers’ needs, and coping strategies. Methods: A qualitative descriptive design was used, involving semi-structured interviews with 21 family caregivers caring for patients with CRC. Participants were recruited purposively from the Medical Center of West Kazakhstan Marat Ospanov Medical University and outpatient clinics in Aktobe between December 2025 and March 2026. Interviews were audio-recorded, transcribed verbatim, and analyzed using inductive reflexive thematic analysis. Results: Most family caregivers of patients with colorectal cancer were women (95.2%). Five main themes developed: emotional challenges, transformation of daily life, caregiving tasks, caregivers’ needs and support gaps, and coping strategies and resilience. Diagnosis was described as a distressing experience characterized by shock, fear, and uncertainty. Caregiving substantially disrupted employment, financial stability, and family roles, often requiring work adjustment or leaving the workforce. Caregivers reported insufficient preparation for stoma care and expressed a strong need for structured training. Social isolation was common, as both caregivers and patients experienced a shrinking of their social support networks. Despite substantial burden, caregivers described adaptive responses to ongoing emotional and practical demands, and resilience was a prominent theme. Conclusions: Family caregivers of patients with colorectal cancer in Kazakhstan face interconnected emotional, informational, physical, and system-level challenges, while also drawing on resilience. The findings highlight priorities for support, including structured stoma care education, psychological services, recognition of caregivers’ roles, and improved discharge and transitional care.
- Open Access
- 25 August 2025
- Published by Medical Association of Zenica-Doboj in Medicinski Glasnik
- Vol. 22 (2) , 253-257
Prognostic significance of CD163 expression in colorectal cancer stroma: a retrospective cohort study
Aim. Colorectal cancer (CRC) ranks among the leading causes of cancer-related mortality worldwide, with significant incidence and mortality rates recorded in Kazakhstan. CRC poses a substantial healthcare burden, prompting investigations into novel prognostic markers. Aim. This study investigates the prognostic significance of CD163 expression in patients with colorectal cancer. Methods. This retrospective cohort study was conducted in Aktobe, Kazakhstan, utilizing tissue microarrays from 175 patients diagnosed with Tumor, Node, Metastasis (TNM) stage I–IV colon adenocarcinoma. CD163 expression was assessed through immunohistochemistry. Kaplan-Meier survival analysis was employed to estimate 5-year overall survival, defined as the interval from diagnosis to death or last follow-up. Cox proportional hazards models were used to evaluate the relationship between CD163 expression levels and survival outcomes. Results. High CD163 expression was linked to advanced disease stage of colorectal cancer (p < 0.001), lymphovascular invasion (p < 0.001), perineural invasion (p < 0.001), and Collagen I>30%, A type (p<0.001). CD163 infiltration was a negative prognostic factor for colorectal cancer patients, with higher risks of death in the high CD163 expression group compared to the low CD163 group (HR=5.769, 95% CI 3.194 – 10.42, p<0.001). Conclusion. The findings highlight CD163 as a potential prognostic biomarker in CRC, warranting further investigation into its mechanistic role and therapeutic implications.
- 25 August 2025
- Published by Medical Association of Zenica-Doboj in Medicinski Glasnik
- Vol. 22 (2) , 253-257
Open AccessPrognostic significance of CD163 expression in colorectal cancer stroma: a retrospective cohort study
Aim. Colorectal cancer (CRC) ranks among the leading causes of cancer-related mortality worldwide, with significant incidence and mortality rates recorded in Kazakhstan. CRC poses a substantial healthcare burden, prompting investigations into novel prognostic markers. Aim. This study investigates the prognostic significance of CD163 expression in patients with colorectal cancer. Methods. This retrospective cohort study was conducted in Aktobe, Kazakhstan, utilizing tissue microarrays from 175 patients diagnosed with Tumor, Node, Metastasis (TNM) stage I–IV colon adenocarcinoma. CD163 expression was assessed through immunohistochemistry. Kaplan-Meier survival analysis was employed to estimate 5-year overall survival, defined as the interval from diagnosis to death or last follow-up. Cox proportional hazards models were used to evaluate the relationship between CD163 expression levels and survival outcomes. Results. High CD163 expression was linked to advanced disease stage of colorectal cancer (p < 0.001), lymphovascular invasion (p < 0.001), perineural invasion (p < 0.001), and Collagen I>30%, A type (p<0.001). CD163 infiltration was a negative prognostic factor for colorectal cancer patients, with higher risks of death in the high CD163 expression group compared to the low CD163 group (HR=5.769, 95% CI 3.194 – 10.42, p<0.001). Conclusion. The findings highlight CD163 as a potential prognostic biomarker in CRC, warranting further investigation into its mechanistic role and therapeutic implications.
- 30 June 2024
- Published by Kazakh Institute of Oncology and Radiology in Oncologia i Radiologia Kazakhstana
- Vol. 72 (2)
MYOEPITHELIAL CARCINOMA OF SOFT TISSUES OF THE RIGHT AXILLARY REGION WITH METASTASIS TO THE CECUM: A CLINICAL CASE
Relevance: Myoepithelial carcinoma is a morphologically diverse tumor that arises either de novo or due to the malignant transformation of its benign counterpart, myoepithelium. These are relatively lesser-known lesions rarely found in the head and neck area. Myoepithelial carcinoma (MC) is a rare malignancy primarily found in the salivary gland. MK can be confused with many other tumors outside the salivary glands, as a wide range of cytomorphological and immunohistochemical features characterizes them. Soft tissue MCs are extremely rare, although a salivary gland MC is relatively common and well-known with similar morphology. The histogenesis of soft tissue MC is still unknown. The tumor may have myoepithelial differentiation but is not derived from myoepithelial cells. Due to the rarity of soft tissue MCs, the number of studies and data on this tumor’s clinical and pathological characteristics are limited. In addition, the limited number of diagnostic criteria and prognostic parameters makes diagnosing and treating soft tissue MC difficult. The article describes a rare case of MC, formed from the soft tissues of the axillary region, with metastasis to the cecum. The purpose was to describe the imaging and clinicopathological features of axillary myoepithelial carcinoma of soft tissues with metastasis to the cecum and to form an understanding of this disease. Methods: A rare case of soft tissue CM of the axillary region with metastasis to the cecum is described. A 57-year-old woman complained of lymphadenopathy in the right axillary region in October 2020. Results: According to ultrasound examination, the lymph node is up to 3.0x3.5 cm in the right axillary region. Based on histopathological and immunohistochemical (IHC) data, on 02/03/2022, the final diagnosis was made: MK of the soft tissues of the right axillary region. According to positron emission tomography/computed tomography (PET/CT), after 4 months, a local focus of active accumulation was detected in the projection of the cecum, with an adjacent enlarged regional lymph node of the paracolic group. On January 18, 2023, surgical treatment was performed in the following volume: “Right-sided hemicolectomy.” Histological examination confirmed MC. According to the multidisciplinary team’s (MDG) decision, the patient received 3 courses of targeted therapy. Conclusion: This case report raises awareness and improves MC diagnostics and treatment.
- 30 June 2024
- Published by Kazakh Institute of Oncology and Radiology in Oncologia i Radiologia Kazakhstana
- Vol. 72 (2)
MYOEPITHELIAL CARCINOMA OF SOFT TISSUES OF THE RIGHT AXILLARY REGION WITH METASTASIS TO THE CECUM: A CLINICAL CASE
Relevance: Myoepithelial carcinoma is a morphologically diverse tumor that arises either de novo or due to the malignant transformation of its benign counterpart, myoepithelium. These are relatively lesser-known lesions rarely found in the head and neck area. Myoepithelial carcinoma (MC) is a rare malignancy primarily found in the salivary gland. MK can be confused with many other tumors outside the salivary glands, as a wide range of cytomorphological and immunohistochemical features characterizes them. Soft tissue MCs are extremely rare, although a salivary gland MC is relatively common and well-known with similar morphology. The histogenesis of soft tissue MC is still unknown. The tumor may have myoepithelial differentiation but is not derived from myoepithelial cells. Due to the rarity of soft tissue MCs, the number of studies and data on this tumor’s clinical and pathological characteristics are limited. In addition, the limited number of diagnostic criteria and prognostic parameters makes diagnosing and treating soft tissue MC difficult. The article describes a rare case of MC, formed from the soft tissues of the axillary region, with metastasis to the cecum. The purpose was to describe the imaging and clinicopathological features of axillary myoepithelial carcinoma of soft tissues with metastasis to the cecum and to form an understanding of this disease. Methods: A rare case of soft tissue CM of the axillary region with metastasis to the cecum is described. A 57-year-old woman complained of lymphadenopathy in the right axillary region in October 2020. Results: According to ultrasound examination, the lymph node is up to 3.0x3.5 cm in the right axillary region. Based on histopathological and immunohistochemical (IHC) data, on 02/03/2022, the final diagnosis was made: MK of the soft tissues of the right axillary region. According to positron emission tomography/computed tomography (PET/CT), after 4 months, a local focus of active accumulation was detected in the projection of the cecum, with an adjacent enlarged regional lymph node of the paracolic group. On January 18, 2023, surgical treatment was performed in the following volume: “Right-sided hemicolectomy.” Histological examination confirmed MC. According to the multidisciplinary team’s (MDG) decision, the patient received 3 courses of targeted therapy. Conclusion: This case report raises awareness and improves MC diagnostics and treatment.
- 29 March 2024
- Published by Kazakh Institute of Oncology and Radiology in Oncologia i Radiologia Kazakhstana
- Vol. 71 (1)
DNA BREAKS AND REPAIR IN LYMPHOCYTES AS A DIAGNOSTIC MARKER IN PATIENTS WITH GASTRIC CANCER
Relevance: Timely detection of foci of double-strand DNA breaks with subsequent initiation of the repair mechanism plays a crucial role in the overall response to DNA damage. Untimely resolution of double-strand DNA breaks and disruptions in the repair pathway constitute a fundamental mechanism in cancer development and progression. A search for biomarkers is needed to identify foci of double-strand DNA breaks and achieve a better outcome of targeted therapy. The study aimed to identify comparative differences in double-strand breaks and DNA repair activity in γ-H2AX and 53BP1 parameters in conditionally healthy individuals and patients with gastric cancer. Methods: Analysis of focal points of γ-H2AX, 53BP1 with lymphocyte parameters using the automated AKLIDES® system in gastric cancer patients (n=30) and conditionally healthy individuals (n=30). Results: Statistically significant differences were found between conditionally healthy individuals and patients with gastric cancer in γ-H2AX parameters: ‘Total number of breaks’ (p=0.001), ‘Number of nuclei with break foci’ (p=0.015), ‘Average number of breaks per cell’ (p=0.016), ‘Mean value of all break foci per cell’ (p=0.001), and in 53BP1 parameters: ‘Number of nuclei with repair foci’ (p=0.001), ‘Mean intensity of repair fluorescence in arbitrary units’ (p=0.001), ‘Mean number of repairs per cell’ (p=0.001), and ‘Damaged cells with low fluorescence intensity’ (p=0.019). Conclusion: Biomarkers of double-strand DNA breaks with repair activity (γ-H2AX, 53BP1) have clinical significance, contributing to the development of targeted medicine in oncology.
- 29 March 2024
- Published by Kazakh Institute of Oncology and Radiology in Oncologia i Radiologia Kazakhstana
- Vol. 71 (1)
DNA BREAKS AND REPAIR IN LYMPHOCYTES AS A DIAGNOSTIC MARKER IN PATIENTS WITH GASTRIC CANCER
Relevance: Timely detection of foci of double-strand DNA breaks with subsequent initiation of the repair mechanism plays a crucial role in the overall response to DNA damage. Untimely resolution of double-strand DNA breaks and disruptions in the repair pathway constitute a fundamental mechanism in cancer development and progression. A search for biomarkers is needed to identify foci of double-strand DNA breaks and achieve a better outcome of targeted therapy. The study aimed to identify comparative differences in double-strand breaks and DNA repair activity in γ-H2AX and 53BP1 parameters in conditionally healthy individuals and patients with gastric cancer. Methods: Analysis of focal points of γ-H2AX, 53BP1 with lymphocyte parameters using the automated AKLIDES® system in gastric cancer patients (n=30) and conditionally healthy individuals (n=30). Results: Statistically significant differences were found between conditionally healthy individuals and patients with gastric cancer in γ-H2AX parameters: ‘Total number of breaks’ (p=0.001), ‘Number of nuclei with break foci’ (p=0.015), ‘Average number of breaks per cell’ (p=0.016), ‘Mean value of all break foci per cell’ (p=0.001), and in 53BP1 parameters: ‘Number of nuclei with repair foci’ (p=0.001), ‘Mean intensity of repair fluorescence in arbitrary units’ (p=0.001), ‘Mean number of repairs per cell’ (p=0.001), and ‘Damaged cells with low fluorescence intensity’ (p=0.019). Conclusion: Biomarkers of double-strand DNA breaks with repair activity (γ-H2AX, 53BP1) have clinical significance, contributing to the development of targeted medicine in oncology.
- 10 October 2023
- Published by Kazakh Institute of Oncology and Radiology in Oncologia i Radiologia Kazakhstana
- Vol. 69 (3)
PARENCHYMATOUS-STROMAL RATIO IN COLORECTAL CANCER TUMORS AS AN INDICATOR OF METASTASIS
Relevance: Colorectal cancer (CRC) is one of the five most common cancers worldwide and is characterized by trends in incidence, disability, and mortality. A significant recurrence rate and early metastasis characterize CRC. Many meta-analyses in the world literature are aimed at finding factors that determine the probable outcome of the disease. The study aimed to evaluate the role of the parenchymal-stromal ratio in the progression of colorectal cancer. Methods: When microcopying at 40x magnification, the parenchyma (Sp) and stroma (Sm) area were measured in the areas of superficial tumor growth and deep invasion. The parenchymal-stromal ratio (PSR) was calculated using the formula PSS=Sp/Sm, and the correlation with tumor metastasis was determined. Results: With an increase in the depth of tumor invasion, the frequency of metastasis to the liver also increased. The metastasis rate for invasion into the muco-submucosal layer (T1) and the muscular layer (T2) was 4%, respectively. The rate increased to 80% with the involvement of the subserous membrane (T3). Metastases in regional lymph nodes worsened the outcome of the disease threefold. With locally widespread and locally regional in the zone of deep invasion, the parenchymal component predominates over the stroma. PSS is 2.5:1.0 and 1.6:1.0. With CRC disseminated growth in the zone of deep tumor invasion, PSS was 1.0:1.4 with a predominance of the stromal component up to 57%. Conclusion: There is a decrease in PSS in superficial growth zones in disseminated forms of colorectal cancer compared with local and local-regional types of cancer. The predominance of the stromal component in the zone of deep invasion is directly proportional to the high adverse outcome.
- 10 October 2023
- Published by Kazakh Institute of Oncology and Radiology in Oncologia i Radiologia Kazakhstana
- Vol. 69 (3)
PARENCHYMATOUS-STROMAL RATIO IN COLORECTAL CANCER TUMORS AS AN INDICATOR OF METASTASIS
Relevance: Colorectal cancer (CRC) is one of the five most common cancers worldwide and is characterized by trends in incidence, disability, and mortality. A significant recurrence rate and early metastasis characterize CRC. Many meta-analyses in the world literature are aimed at finding factors that determine the probable outcome of the disease. The study aimed to evaluate the role of the parenchymal-stromal ratio in the progression of colorectal cancer. Methods: When microcopying at 40x magnification, the parenchyma (Sp) and stroma (Sm) area were measured in the areas of superficial tumor growth and deep invasion. The parenchymal-stromal ratio (PSR) was calculated using the formula PSS=Sp/Sm, and the correlation with tumor metastasis was determined. Results: With an increase in the depth of tumor invasion, the frequency of metastasis to the liver also increased. The metastasis rate for invasion into the muco-submucosal layer (T1) and the muscular layer (T2) was 4%, respectively. The rate increased to 80% with the involvement of the subserous membrane (T3). Metastases in regional lymph nodes worsened the outcome of the disease threefold. With locally widespread and locally regional in the zone of deep invasion, the parenchymal component predominates over the stroma. PSS is 2.5:1.0 and 1.6:1.0. With CRC disseminated growth in the zone of deep tumor invasion, PSS was 1.0:1.4 with a predominance of the stromal component up to 57%. Conclusion: There is a decrease in PSS in superficial growth zones in disseminated forms of colorectal cancer compared with local and local-regional types of cancer. The predominance of the stromal component in the zone of deep invasion is directly proportional to the high adverse outcome.
- 30 September 2023
- Published by Kazakh Institute of Oncology and Radiology in Oncologia i Radiologia Kazakhstana
- Vol. 69 (3)
PARENCHYMATOUS-STROMAL RATIO IN COLORECTAL CANCER TUMORS AS AN INDICATOR OF METASTASIS
Relevance: Colorectal cancer (CRC) is one of the five most common cancers worldwide and is characterized by trends in incidence, disability, and mortality. A significant recurrence rate and early metastasis characterize CRC. Many meta-analyses in the world literature are aimed at finding factors that determine the probable outcome of the disease. ДИАГНОСТИКА Онкология и Радиология Казахстана, №3 (69) 2023 37 The study aimed to evaluate the role of the parenchymal-stromal ratio in the progression of colorectal cancer. Methods: When microcopying at 40x magnification, the parenchyma (Sp) and stroma (Sm) area were measured in the areas of superficial tumor growth and deep invasion. The parenchymal-stromal ratio (PSR) was calculated using the formula PSS=Sp/Sm, and the correlation with tumor metastasis was determined. Results: With an increase in the depth of tumor invasion, the frequency of metastasis to the liver also increased. The metastasis rate for invasion into the muco-submucosal layer (T1) and the muscular layer (T2) was 4%, respectively. The rate increased to 80% with the involvement of the subserous membrane (T3). Metastases in regional lymph nodes worsened the outcome of the disease threefold. With locally widespread and locally regional in the zone of deep invasion, the parenchymal component predominates over the stroma. PSS is 2.5:1.0 and 1.6:1.0. With CRC disseminated growth in the zone of deep tumor invasion, PSS was 1.0:1.4 with a predominance of the stromal component up to 57%. Conclusion: There is a decrease in PSS in superficial growth zones in disseminated forms of colorectal cancer compared with local and local-regional types of cancer. The predominance of the stromal component in the zone of deep invasion is directly proportional to the high adverse outcome.
- 30 September 2023
- Published by Kazakh Institute of Oncology and Radiology in Oncologia i Radiologia Kazakhstana
- Vol. 69 (3)
PARENCHYMATOUS-STROMAL RATIO IN COLORECTAL CANCER TUMORS AS AN INDICATOR OF METASTASIS
Relevance: Colorectal cancer (CRC) is one of the five most common cancers worldwide and is characterized by trends in incidence, disability, and mortality. A significant recurrence rate and early metastasis characterize CRC. Many meta-analyses in the world literature are aimed at finding factors that determine the probable outcome of the disease. ДИАГНОСТИКА Онкология и Радиология Казахстана, №3 (69) 2023 37 The study aimed to evaluate the role of the parenchymal-stromal ratio in the progression of colorectal cancer. Methods: When microcopying at 40x magnification, the parenchyma (Sp) and stroma (Sm) area were measured in the areas of superficial tumor growth and deep invasion. The parenchymal-stromal ratio (PSR) was calculated using the formula PSS=Sp/Sm, and the correlation with tumor metastasis was determined. Results: With an increase in the depth of tumor invasion, the frequency of metastasis to the liver also increased. The metastasis rate for invasion into the muco-submucosal layer (T1) and the muscular layer (T2) was 4%, respectively. The rate increased to 80% with the involvement of the subserous membrane (T3). Metastases in regional lymph nodes worsened the outcome of the disease threefold. With locally widespread and locally regional in the zone of deep invasion, the parenchymal component predominates over the stroma. PSS is 2.5:1.0 and 1.6:1.0. With CRC disseminated growth in the zone of deep tumor invasion, PSS was 1.0:1.4 with a predominance of the stromal component up to 57%. Conclusion: There is a decrease in PSS in superficial growth zones in disseminated forms of colorectal cancer compared with local and local-regional types of cancer. The predominance of the stromal component in the zone of deep invasion is directly proportional to the high adverse outcome.
- Open Access
- 28 June 2023
- Published by JSC National Scientific Medical Research Center in Journal of Clinical Medicine of Kazakhstan
- Vol. 20 (3) , 75-81
Stratifying breast cancer patients by baseline risk of cardiotoxic complications linked to chemotherapy
A majority of modern antitumor pharmaceuticals are accompanied by cardiotoxicity. The study aims to present practical approaches to stratifying the baseline risk of antitumor therapies' cardiotoxicity in patients newly diagnosed with breast cancer started on anthracyclines and/or trastuzumab. Material and methods: Stratifying the risks of antitumor therapy was carried out according to the European Society of Cardiology recommendations. A therapist examined all patients for existing cardiovascular diseases and risk factors detection. The blood levels of glucose, cholesterol, creatinine, cardiac troponin I, and brain natriuretic peptide were determined. Electrocardiography and echocardiography with an assessment of the myocardium global longitudinal strain were performed. Results: In total, 128 breast cancer patients with a mean age of 54.3±11.0 years were included in the study. Of them, 84.4% had tumor stages I and II, and 21.1% were HER2-positive. Chronic heart failure and ischemic heart disease were detected in 2.3%. Among the risk factors, the most common were arterial hypertension (51.6%), obesity (29.7%), age 65-70 years (18%), significant smoking history (15.6%), and diabetes mellitus (11.7%). Elevated cardiac troponin I and brain natriuretic peptide baseline levels were present in 5.5% and 7.0% of patients, respectively. To a high-risk group for cardiotoxic complications, 7.8% were allocated, 35.7% were assigned to the moderate-risk group, and 54.7% had low risk. High/very high and moderate-risk patients (43.5%) were referred to a cardiologist. Cardioprotective treatment was started immediately in high/very high-risk patients. Conclusion: All revealed differences between the cardiovascular risk groups were related to age, cardiovascular system condition, and the severity of comorbid pathologies. The baseline stratification of patients into risk groups is a crucial step in preventing the cardiotoxicity of anticancer therapy. Comprehensive assessing the patient's condition before and during chemotherapy allows for avoiding the development of fatal cardiovascular complications in at-risk patients.
- 28 June 2023
- Published by JSC National Scientific Medical Research Center in Journal of Clinical Medicine of Kazakhstan
- Vol. 20 (3) , 75-81
Open AccessStratifying breast cancer patients by baseline risk of cardiotoxic complications linked to chemotherapy
A majority of modern antitumor pharmaceuticals are accompanied by cardiotoxicity. The study aims to present practical approaches to stratifying the baseline risk of antitumor therapies' cardiotoxicity in patients newly diagnosed with breast cancer started on anthracyclines and/or trastuzumab. Material and methods: Stratifying the risks of antitumor therapy was carried out according to the European Society of Cardiology recommendations. A therapist examined all patients for existing cardiovascular diseases and risk factors detection. The blood levels of glucose, cholesterol, creatinine, cardiac troponin I, and brain natriuretic peptide were determined. Electrocardiography and echocardiography with an assessment of the myocardium global longitudinal strain were performed. Results: In total, 128 breast cancer patients with a mean age of 54.3±11.0 years were included in the study. Of them, 84.4% had tumor stages I and II, and 21.1% were HER2-positive. Chronic heart failure and ischemic heart disease were detected in 2.3%. Among the risk factors, the most common were arterial hypertension (51.6%), obesity (29.7%), age 65-70 years (18%), significant smoking history (15.6%), and diabetes mellitus (11.7%). Elevated cardiac troponin I and brain natriuretic peptide baseline levels were present in 5.5% and 7.0% of patients, respectively. To a high-risk group for cardiotoxic complications, 7.8% were allocated, 35.7% were assigned to the moderate-risk group, and 54.7% had low risk. High/very high and moderate-risk patients (43.5%) were referred to a cardiologist. Cardioprotective treatment was started immediately in high/very high-risk patients. Conclusion: All revealed differences between the cardiovascular risk groups were related to age, cardiovascular system condition, and the severity of comorbid pathologies. The baseline stratification of patients into risk groups is a crucial step in preventing the cardiotoxicity of anticancer therapy. Comprehensive assessing the patient's condition before and during chemotherapy allows for avoiding the development of fatal cardiovascular complications in at-risk patients.
- Open Access
- 25 February 2022
- Published by JSC National Scientific Medical Research Center in Journal of Clinical Medicine of Kazakhstan
- Vol. 19 (1) , 28-35
A first approach to identifying cardiotoxic effects of breast cancer chemotherapeutic treatment in Kazakhstan
As known, the clinical efficacy of chemotherapy is limited by the cardiotoxicity of drugs used. The study aimed to clarify cardiotoxic complications of chemotherapy from the Aktobe Medical Center database for 2018-2019. Material and methods: We performed a register study on essential parameters of the oncological process, drugs used, duration of chemotherapy, types of complications, and outcomes, including survival. Results: We found a total of 305 breast cancer cases. Chemotherapy was completed without complications in 65.9% of patients; treatment was interrupted due to complications - 10.5%; 6.2% of cardiovascular complications were identified. The two groups of patients, EchoCG + and EchoCG -, showed significant difference in the number of detected CV complications (p<.001) but no difference in the survival rate (p .814). The survival rate in patients with documented CV complications was 28.1 months vs. 34.3 months in the group without ones (p.005). The survival rate in those who completed the treatment without complications, was 34.9 months vs. 17.6 in individuals whose treatment was interrupted due to complications (p<.001). We performed a detailed review of four cases of cardiotoxicity with fatal outcomes. Conclusion: The analysis indicates the absence of a systematic approach to recording crucial information regarding cardiotoxicity. There is a lack of concordance in the actions of cardiologists and oncologists in the management of BC patients. The presence of lethal outcomes of chemotherapy with an established cause of cardiac death indicates the need to revise the cancer register management from the standpoint of cardio-oncology. In general, there is a need to develop local protocols for screening and monitoring patients undergoing cardiotoxic chemotherapy and radiation therapy.
- 25 February 2022
- Published by JSC National Scientific Medical Research Center in Journal of Clinical Medicine of Kazakhstan
- Vol. 19 (1) , 28-35
Open AccessA first approach to identifying cardiotoxic effects of breast cancer chemotherapeutic treatment in Kazakhstan
As known, the clinical efficacy of chemotherapy is limited by the cardiotoxicity of drugs used. The study aimed to clarify cardiotoxic complications of chemotherapy from the Aktobe Medical Center database for 2018-2019. Material and methods: We performed a register study on essential parameters of the oncological process, drugs used, duration of chemotherapy, types of complications, and outcomes, including survival. Results: We found a total of 305 breast cancer cases. Chemotherapy was completed without complications in 65.9% of patients; treatment was interrupted due to complications - 10.5%; 6.2% of cardiovascular complications were identified. The two groups of patients, EchoCG + and EchoCG -, showed significant difference in the number of detected CV complications (p<.001) but no difference in the survival rate (p .814). The survival rate in patients with documented CV complications was 28.1 months vs. 34.3 months in the group without ones (p.005). The survival rate in those who completed the treatment without complications, was 34.9 months vs. 17.6 in individuals whose treatment was interrupted due to complications (p<.001). We performed a detailed review of four cases of cardiotoxicity with fatal outcomes. Conclusion: The analysis indicates the absence of a systematic approach to recording crucial information regarding cardiotoxicity. There is a lack of concordance in the actions of cardiologists and oncologists in the management of BC patients. The presence of lethal outcomes of chemotherapy with an established cause of cardiac death indicates the need to revise the cancer register management from the standpoint of cardio-oncology. In general, there is a need to develop local protocols for screening and monitoring patients undergoing cardiotoxic chemotherapy and radiation therapy.
- 10 June 2020
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 26 (18) , 2073-2086
Human Papillomavirus Selected Properties and Related Cervical Cancer Prevention Issues
High-risk human papillomavirus strains are widely known to be the causative agents responsible for cervical cancer development. Aggregated damage caused by papillomaviruses solely is estimated in at least 5% of all malignancies of the human body and 16% in cancers that affect the female genital area. Enhanced understanding of the complex issue on how the high extent of carcinogenicity is eventually formed due to the infection by the Papoviridae family would contribute to enhancing current prevention strategies not only towards cervical cancer, but also other HPV associated cancers. This review article is aimed at presenting the key points in two directions: the current cervical cancer prevention and related aspects of HPV behavior. Virtually all applied technologies related to HPV diagnostics and screening programs, such as HPV tests, colposcopy-based tests (VIA/VILI), conventional and liquid-based cytology, currently available are presented. Issues of availability, advantages, and drawbacks of the screening programs, as well as vaccination strategies, are also reviewed in the article based on the analyzed sources. The current point of view regarding HPV is discussed with emphasis on the most problematic aspect of the HPV family concerning the observed increasing number of highly carcinogenic types. Present trends in HPV infection diagnostics throughout the human fluids and tissues are also reported, including the latest novelties in this field, such as HPV assay/self-sample device combinations. Besides, a brief outline of the related prevention issues in Kazakhstan, the leading country of Central Asia, is presented. Kazakhstan, as one of the post-soviet middle-income countries, may serve as an example of the current situation in those terrains, concerning the implementation of globally accepted cervical cancer prevention strategies. Along with positive achievements, such as the development of a nationwide screening program, a range of drawbacks is also analyzed and discussed.
- 10 June 2020
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 26 (18) , 2073-2086
Human Papillomavirus Selected Properties and Related Cervical Cancer Prevention Issues
High-risk human papillomavirus strains are widely known to be the causative agents responsible for cervical cancer development. Aggregated damage caused by papillomaviruses solely is estimated in at least 5% of all malignancies of the human body and 16% in cancers that affect the female genital area. Enhanced understanding of the complex issue on how the high extent of carcinogenicity is eventually formed due to the infection by the Papoviridae family would contribute to enhancing current prevention strategies not only towards cervical cancer, but also other HPV associated cancers. This review article is aimed at presenting the key points in two directions: the current cervical cancer prevention and related aspects of HPV behavior. Virtually all applied technologies related to HPV diagnostics and screening programs, such as HPV tests, colposcopy-based tests (VIA/VILI), conventional and liquid-based cytology, currently available are presented. Issues of availability, advantages, and drawbacks of the screening programs, as well as vaccination strategies, are also reviewed in the article based on the analyzed sources. The current point of view regarding HPV is discussed with emphasis on the most problematic aspect of the HPV family concerning the observed increasing number of highly carcinogenic types. Present trends in HPV infection diagnostics throughout the human fluids and tissues are also reported, including the latest novelties in this field, such as HPV assay/self-sample device combinations. Besides, a brief outline of the related prevention issues in Kazakhstan, the leading country of Central Asia, is presented. Kazakhstan, as one of the post-soviet middle-income countries, may serve as an example of the current situation in those terrains, concerning the implementation of globally accepted cervical cancer prevention strategies. Along with positive achievements, such as the development of a nationwide screening program, a range of drawbacks is also analyzed and discussed.
- Open Access
- 8 March 2020
- Published by Georg Thieme Verlag KG in Journal of Coloproctology
- Vol. 40 (01) , 043-049
Trends in colorectal cancer incidence in western Kazakhstan through the first decade of the screening implementation, 2009‒2018
Introduction The study is aimed to outline the vector of colorectal cancer incidence in the industrial Aktobe province of western Kazakhstan through the first decade of the screening implementation, 2009–2018. Methods Rough incidence rates and annual percent changes were estimated for each age group at diagnosis, ethnicities, gender, residences, the disease stages and anatomic subsites (total N 1128) via regression analysis. Results Within 2009–2018 colorectal cancer rates increased from 14.74 to 23.19, with annual percent changes of 4.69%. The most significant growth was traced in men compared to women, up to 28.39 by 2018, with annual percent changes 6.64% vs. 2.64% (p = 0.0009). Annual percent changes in Kazakhs reached 8.7%, whereas Slavic groups showed decline in the incidence, annual percent changes −4.3% (p = 0.002). Declining in rates was also observed in urban population compared to rural one, annual percent changes −3.3% vs. 17.6%, respectively. Patients aged 60–69 made 31% of all cases and showed the largest annual percent changes 9.37% (p = 0.002). Patients at Stage II made 61% of all observations, but general trend evidenced sharp growth in the group of Stage I (annual percent changes 28.91%, p < 0.0001). Conclusion Overall, during the last decade colorectal cancer incidence increased 1.5 fold with expected further rise. However, the increment of Stage I portion by 2018 vs. advanced stages at diagnosis and the trend to decrease in rates among urban population inspire a definite assurance in potential efficiency of the screening program in long run. The next researches on colorectal cancer should include scenarios to reveal the role of disadvantaged environment in the region and consuming unhealthy ultra-processed food.
- 8 March 2020
- Published by Georg Thieme Verlag KG in Journal of Coloproctology
- Vol. 40 (01) , 043-049
Open AccessTrends in colorectal cancer incidence in western Kazakhstan through the first decade of the screening implementation, 2009‒2018
Introduction The study is aimed to outline the vector of colorectal cancer incidence in the industrial Aktobe province of western Kazakhstan through the first decade of the screening implementation, 2009–2018. Methods Rough incidence rates and annual percent changes were estimated for each age group at diagnosis, ethnicities, gender, residences, the disease stages and anatomic subsites (total N 1128) via regression analysis. Results Within 2009–2018 colorectal cancer rates increased from 14.74 to 23.19, with annual percent changes of 4.69%. The most significant growth was traced in men compared to women, up to 28.39 by 2018, with annual percent changes 6.64% vs. 2.64% (p = 0.0009). Annual percent changes in Kazakhs reached 8.7%, whereas Slavic groups showed decline in the incidence, annual percent changes −4.3% (p = 0.002). Declining in rates was also observed in urban population compared to rural one, annual percent changes −3.3% vs. 17.6%, respectively. Patients aged 60–69 made 31% of all cases and showed the largest annual percent changes 9.37% (p = 0.002). Patients at Stage II made 61% of all observations, but general trend evidenced sharp growth in the group of Stage I (annual percent changes 28.91%, p < 0.0001). Conclusion Overall, during the last decade colorectal cancer incidence increased 1.5 fold with expected further rise. However, the increment of Stage I portion by 2018 vs. advanced stages at diagnosis and the trend to decrease in rates among urban population inspire a definite assurance in potential efficiency of the screening program in long run. The next researches on colorectal cancer should include scenarios to reveal the role of disadvantaged environment in the region and consuming unhealthy ultra-processed food.